tradingkey.logo

Mckesson Corp

MCK
813.800USD
0.000
Close 12/15, 16:00ETQuotes delayed by 15 min
100.91BMarket Cap
25.32P/E TTM

Mckesson Corp

813.800
0.000
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Mckesson Corp

Currency: USD Updated: 2025-12-12

Key Insights

Mckesson Corp's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 6/159 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 934.03.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Mckesson Corp's Score

Industry at a Glance

Industry Ranking
6 / 159
Overall Ranking
36 / 4592
Industry
Pharmaceuticals

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 18 analysts
Buy
Current Rating
934.031
Target Price
+17.06%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Mckesson Corp Highlights

StrengthsRisks
McKesson Corporation is a diversified healthcare services company, which focuses on advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products in the United States (U.S.). The Prescription Technology Solutions (RxTS) segment helps solve medication access, affordability and adherence challenges for patients by working across healthcare to connect patients, pharmacies, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, hospital reference labs, and home healthcare agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Canada and Norway. It also offers oncology and specialty solutions.
Industry Leader
The company's revenue leads the industry, with the latest annual revenue totaling USD 359.05B.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 29.76% year-on-year.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 10.68%.
Fairly Valued
The company’s latest PE is 25.32, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 112.70M shares, decreasing 1.97% quarter-over-quarter.
Held by Ken Fisher
Star Investor Ken Fisher holds 1.74K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.19.

Financial Health

Currency: USD Updated: 2025-12-12

The current financial score of Mckesson Corp is 8.85, ranking 31/159 in the Pharmaceuticals industry. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 103.15B, representing a year-over-year increase of 10.14%, while its net profit experienced a year-over-year increase of 360.58%.

Score

Industry at a Glance

Previous score
8.85
Change
0

Financials

5.18

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

9.36

Operational Efficiency

10.00

Growth Potential

10.00

Shareholder Returns

9.73

Mckesson Corp's Company Valuation

Currency: USD Updated: 2025-12-12

The current valuation score of Mckesson Corp is 8.51, ranking 17/159 in the Pharmaceuticals industry. Its current P/E ratio is 25.32, which is 35.13% below the recent high of 34.22 and 44.59% above the recent low of 14.03.

Score

Industry at a Glance

Previous score
8.51
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 6/159
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2025-12-12

The current earnings forecast score of Mckesson Corp is 8.47, ranking 34/159 in the Pharmaceuticals industry. The average price target for Mckesson Corp is 955.00, with a high of 1000.00 and a low of 757.50.

Score

Industry at a Glance

Previous score
8.47
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 18 analysts
Buy
Current Rating
934.031
Target Price
+17.06%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

171
Total
6
Median
8
Average
Company name
Ratings
Analysts
McKesson Corp
MCK
18
Biogen Inc
BIIB
36
Amgen Inc
AMGN
35
Eli Lilly and Co
LLY
33
Vertex Pharmaceuticals Inc
VRTX
33
AbbVie Inc
ABBV
32
1
2
3
...
34

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-12-12

The current price momentum score of Mckesson Corp is 7.06, ranking 87/159 in the Pharmaceuticals industry. Currently, the stock price is trading between the resistance level at 876.27 and the support level at 770.65, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
7.09
Change
-0.03

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(2)
Neutral(3)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
-10.127
Neutral
RSI(14)
48.700
Neutral
STOCH(KDJ)(9,3,3)
50.959
Buy
ATR(14)
17.785
Low Volatility
CCI(14)
-28.253
Neutral
Williams %R
68.709
Sell
TRIX(12,20)
-0.129
Sell
StochRSI(14)
100.000
Overbought
Moving Average
Sell(2)
Neutral(0)
Buy(4)
Indicators
Value
Direction
MA5
812.092
Buy
MA10
811.626
Buy
MA20
839.070
Sell
MA50
818.849
Sell
MA100
761.054
Buy
MA200
728.963
Buy

Institutional Confidence

Currency: USD Updated: 2025-12-12

The current institutional shareholding score of Mckesson Corp is 10.00, ranking 1/159 in the Pharmaceuticals industry. The latest institutional shareholding proportion is 90.60%, representing a quarter-over-quarter increase of 0.86%. The largest institutional shareholder is The Vanguard, holding a total of 11.97M shares, representing 9.70% of shares outstanding, with 2.98% increase in holdings.

Score

Industry at a Glance

Previous score
10.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
The Vanguard Group, Inc.
Star Investors
12.01M
+1.95%
BlackRock Institutional Trust Company, N.A.
6.74M
+2.60%
State Street Investment Management (US)
5.70M
+0.10%
MFS Investment Management
3.92M
-13.58%
Geode Capital Management, L.L.C.
2.82M
+4.14%
Fidelity Management & Research Company LLC
1.91M
+39.37%
AllianceBernstein L.P.
2.27M
+150.44%
Putnam Investment Management, L.L.C.
2.27M
-6.82%
Norges Bank Investment Management (NBIM)
1.84M
-12.75%
JP Morgan Asset Management
3.45M
+12.28%
1
2

Risk Assessment

Currency: USD Updated: 2025-12-12

The current risk assessment score of Mckesson Corp is 9.73, ranking 4/159 in the Pharmaceuticals industry. The company's beta value is 0.40. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Score

Industry at a Glance

Previous score
9.73
Change
0
Beta vs S&P 500 index
0.41
VaR
+2.05%
240-Day Maximum Drawdown
+10.60%
240-Day Volatility
+26.78%

Return

Best Daily Return
60 days
+6.36%
120 days
+6.36%
5 years
+10.60%
Worst Daily Return
60 days
-3.17%
120 days
-5.76%
5 years
-11.34%
Sharpe Ratio
60 days
+2.88
120 days
+1.24
5 years
+1.55

Risk Assessment

Maximum Drawdown
240 days
+10.60%
3 years
+24.00%
5 years
+24.00%
Return-to-Drawdown Ratio
240 days
+4.17
3 years
+1.69
5 years
+3.05
Skewness
240 days
-0.21
3 years
-0.60
5 years
-0.30

Volatility

Realised Volatility
240 days
+26.78%
5 years
+25.00%
Standardised True Range
240 days
+1.95%
5 years
+1.14%
Downside Risk-Adjusted Return
120 days
+171.52%
240 days
+171.52%
Maximum Daily Upside Volatility
60 days
+20.35%
Maximum Daily Downside Volatility
60 days
+22.44%

Liquidity

Average Turnover Rate
60 days
+0.62%
120 days
+0.74%
5 years
--
Turnover Deviation
20 days
+19.26%
60 days
-5.29%
120 days
+12.70%

Peer Comparison

Pharmaceuticals
Mckesson Corp
Mckesson Corp
MCK
8.57 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Jazz Pharmaceuticals PLC
Jazz Pharmaceuticals PLC
JAZZ
8.88 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Prestige Consumer Healthcare Inc
Prestige Consumer Healthcare Inc
PBH
8.72 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Collegium Pharmaceutical Inc
Collegium Pharmaceutical Inc
COLL
8.69 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Catalyst Pharmaceuticals Inc
Catalyst Pharmaceuticals Inc
CPRX
8.63 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
United Therapeutics Corp
United Therapeutics Corp
UTHR
8.61 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more

FAQs

How does TradingKey generate the Stock Score of Mckesson Corp?

The TradingKey Stock Score provides a comprehensive assessment of Mckesson Corp based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Mckesson Corp’s performance and outlook.

How do we generate the financial health score of Mckesson Corp?

To generate the financial health score of Mckesson Corp, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects Mckesson Corp's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Mckesson Corp.

How do we generate the company valuation score of Mckesson Corp?

To generate the company valuation score of Mckesson Corp, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Mckesson Corp’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Mckesson Corp’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Mckesson Corp.

How do we generate the earnings forecast score of Mckesson Corp?

To calculate the earnings forecast score of Mckesson Corp, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Mckesson Corp’s future.

How do we generate the price momentum score of Mckesson Corp?

When generating the price momentum score for Mckesson Corp, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of Mckesson Corp’s prices. A higher score indicates a more stable short-term price trend for Mckesson Corp.

How do we generate the institutional confidence score of Mckesson Corp?

To generate the institutional confidence score of Mckesson Corp, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Mckesson Corp’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Mckesson Corp.

How do we generate the risk management score of Mckesson Corp?

To assess the risk management score of Mckesson Corp, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of Mckesson Corp’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Mckesson Corp.
KeyAI